Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
proteomics
MedTech
Thermo Fisher debuts protein panel for neurodegeneration R&D
The addition of the multiplex immunoassay panel to the company’s Target 48 proteomics line follows last year’s $3.1 billion acquisition of Olink.
Conor Hale
Sep 16, 2025 12:00pm
Illumina begins rolling out protein analysis platform
Sep 3, 2025 2:30pm
VantAI plays matchmaker for Halda's RIPTACs in $1B deal
Aug 19, 2025 8:00am
Illumina picks up proteomics developer SomaLogic for $425M
Jun 23, 2025 11:00am
Thermo Fisher collects green lights for $3.1B Olink takeover
Jul 8, 2024 10:25am
Protein parser Alamar Bio collects $128M for analyzer launch
Mar 1, 2024 10:58am
